Literature DB >> 20171504

Radiation-associated kidney injury.

Laura A Dawson1, Brian D Kavanagh, Arnold C Paulino, Shiva K Das, Moyed Miften, X Allen Li, Charlie Pan, Randall K Ten Haken, Timothy E Schultheiss.   

Abstract

The kidneys are the dose-limiting organs for radiotherapy to upper abdominal cancers and during total body irradiation. The incidence of radiotherapy-associated kidney injury is likely underreported owing to its long latency and because the toxicity is often attributed to more common causes of kidney injury. The pathophysiology of radiation injury is poorly understood. Its presentation can be acute and irreversible or subtle, with a gradual progressive dysfunction over years. A variety of dose and volume parameters have been associated with renal toxicity and are reviewed to provide treatment guidelines. The available predictive models are suboptimal and require validation. Mitigation of radiation nephropathy with angiotensin-converting enzyme inhibitors and other compounds has been shown in animal models and, more recently, in patients. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20171504     DOI: 10.1016/j.ijrobp.2009.02.089

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  73 in total

1.  Model development and use of ACE inhibitors for preclinical mitigation of radiation-induced injury to multiple organs.

Authors:  Meetha Medhora; Feng Gao; Qingping Wu; Robert C Molthen; Elizabeth R Jacobs; John E Moulder; Brian L Fish
Journal:  Radiat Res       Date:  2014-10-31       Impact factor: 2.841

Review 2.  Stereotactic body radiotherapy for the treatment of medically inoperable primary renal cell carcinoma: Current evidence and future directions.

Authors:  Anand Swaminath; William Chu
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

Review 3.  Proton beam therapy for gastrointestinal cancers: past, present, and future.

Authors:  Shahed N Badiyan; Christopher L Hallemeier; Steven H Lin; Matthew D Hall; Michael D Chuong
Journal:  J Gastrointest Oncol       Date:  2018-10

4.  Basal renal function reserve and mean kidney dose predict future radiation-induced kidney injury in stomach cancer patients.

Authors:  Guler Yavas; Rengin Elsurer; Cagdas Yavas; Ozlem Ata
Journal:  Support Care Cancer       Date:  2013-10-03       Impact factor: 3.603

Review 5.  [Imaging of side effects after radiation therapy].

Authors:  T Welzel; J M Tanner
Journal:  Radiologe       Date:  2018-08       Impact factor: 0.635

6.  Predicting, preventing, treating and understanding radiation nephropathy.

Authors:  Heath D Skinner; Sunil Krishnan
Journal:  J Gastrointest Oncol       Date:  2010-09

Review 7.  Modelling and dosimetry for alpha-particle therapy.

Authors:  George Sgouros; Robert F Hobbs; Hong Song
Journal:  Curr Radiopharm       Date:  2011-07

8.  Renal Function Outcomes of High-risk Neuroblastoma Patients Undergoing Radiation Therapy.

Authors:  Thomas H Beckham; Dana L Casey; Michael P LaQuaglia; Brian H Kushner; Shakeel Modak; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-11       Impact factor: 7.038

9.  Liquid Chromatography-Mass Spectrometry-Based Metabolomics of Nonhuman Primates after 4 Gy Total Body Radiation Exposure: Global Effects and Targeted Panels.

Authors:  Evan L Pannkuk; Evagelia C Laiakis; Kirandeep Gill; Shreyans K Jain; Khyati Y Mehta; Denise Nishita; Kim Bujold; James Bakke; Janet Gahagen; Simon Authier; Polly Chang; Albert J Fornace
Journal:  J Proteome Res       Date:  2019-03-18       Impact factor: 4.466

10.  Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model.

Authors:  Jessie R Nedrow; Anders Josefsson; Sunju Park; Tom Bäck; Robert F Hobbs; Cory Brayton; Frank Bruchertseifer; Alfred Morgenstern; George Sgouros
Journal:  EJNMMI Res       Date:  2017-07-18       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.